Aspiriant LLC’s Vanguard FTSE Emerging Markets ETF VWO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.14M Buy
150,691
+10,558
+8% +$591K 0.23% 52
2025
Q4
$7.53M Buy
140,133
+29,198
+26% +$1.59M 0.22% 58
2025
Q3
$6.01M Buy
110,935
+2,093
+2% +$108K 0.18% 59
2025
Q2
$5.38M Buy
108,842
+515
+0.5% +$23.9K 0.17% 58
2025
Q1
$4.9M Sell
108,327
-2,096
-2% -$94.3K 0.17% 57
2024
Q4
$4.86M Buy
110,423
+7,744
+8% +$360K 0.18% 58
2024
Q3
$4.91M Sell
102,679
-995
-1% -$44.3K 0.19% 55
2024
Q2
$4.54M Buy
103,674
+9,660
+10% +$416K 0.18% 57
2024
Q1
$3.93M Sell
94,014
-10,686
-10% -$436K 0.16% 60
2023
Q4
$4.3M Sell
104,700
-2,912
-3% -$116K 0.19% 58
2023
Q3
$4.22M Sell
107,612
-3,060
-3% -$125K 0.22% 57
2023
Q2
$4.5M Sell
110,672
-5,466
-5% -$220K 0.23% 54
2023
Q1
$4.69M Sell
116,138
-920
-0.8% -$37.5K 0.25% 53
2022
Q4
$4.56M Sell
117,058
-6,639
-5% -$253K 0.23% 53
2022
Q3
$4.51M Buy
123,697
+708
+0.6% +$28.7K 0.22% 51
2022
Q2
$5.12M Buy
122,989
+7,953
+7% +$343K 0.25% 51
2022
Q1
$5.3M Sell
115,036
-1,503
-1% -$72.3K 0.29% 48
2021
Q4
$5.76M Buy
116,539
+2,379
+2% +$120K 0.31% 45
2021
Q3
$5.71M Sell
114,160
-6,454
-5% -$333K 0.34% 35
2021
Q2
$6.55M Buy
120,614
+3,237
+3% +$172K 0.37% 31
2021
Q1
$6.11M Sell
117,377
-7,316
-6% -$389K 0.39% 29
2020
Q4
$6.25M Sell
124,693
-8,069
-6% -$379K 0.43% 29
2020
Q3
$5.75M Buy
132,762
+1,737
+1% +$75.5K 0.45% 32
2020
Q2
$5.19M Sell
131,025
-24,164
-16% -$895K 0.48% 30
2020
Q1
$5.2M Sell
155,189
-44,621
-22% -$1.82M 0.51% 29
2019
Q4
$8.89M Buy
199,810
+4,000
+2% +$169K 0.82% 24
2019
Q3
$7.88M Sell
195,810
-829
-0.4% -$34.2K 0.71% 27
2019
Q2
$8.37M Buy
196,639
+8,474
+5% +$357K 0.7% 28
2019
Q1
$8M Buy
188,165
+8,347
+5% +$344K 0.65% 34
2018
Q4
$6.85M Sell
179,818
-947
-0.5% -$36.7K 0.52% 35
2018
Q3
$7.41M Sell
180,765
-1,342
-0.7% -$56.5K 0.63% 33
2018
Q2
$7.68M Sell
182,107
-13,735
-7% -$620K 0.66% 33
2018
Q1
$9.2M Buy
195,842
+102,781
+110% +$4.93M 0.8% 32
2017
Q4
$4.27M Sell
93,061
-102,065
-52% -$4.56M 1.25% 20
2017
Q3
$8.5M Sell
195,126
-12,835
-6% -$555K 0.71% 33
2017
Q2
$8.49M Buy
207,961
+13,849
+7% +$561K 0.74% 32
2017
Q1
$7.71M Buy
194,112
+34,513
+22% +$1.33M 0.66% 32
2016
Q4
$5.71M Sell
159,599
-23,010
-13% -$843K 0.52% 30
2016
Q3
$6.87M Sell
182,609
-16,145
-8% -$601K 0.68% 24
2016
Q2
$7M Buy
198,754
+287
+0.1% +$9.8K 0.66% 22
2016
Q1
$6.86M Sell
198,467
-33,872
-15% -$1.06M 0.65% 22
2015
Q4
$7.6M Sell
232,339
-671,903
-74% -$23.1M 0.84% 17
2015
Q3
$34.3M Buy
904,242
+339,710
+60% +$12.3M 2.85% 13
2015
Q2
$23.1M Buy
564,532
+223,669
+66% +$9.61M 2.25% 12
2015
Q1
$13.9M Sell
340,863
-38,614
-10% -$1.57M 1.81% 12
2014
Q4
$15.2M Sell
379,477
-38,709
-9% -$1.59M 2.03% 12
2014
Q3
$17.4M Sell
418,186
-6,174
-1% -$274K 2.44% 10
2014
Q2
$18.3M Sell
424,360
-38,631
-8% -$1.63M 2.52% 10
2014
Q1
$18.8M Buy
462,991
+17,066
+4% +$662K 2.72% 9
2013
Q4
$18.3M Buy
445,925
+165,975
+59% +$6.84M 2.86% 9
2013
Q3
$11.2M Sell
279,950
-313,012
-53% -$12.4M 2.01% 8
2013
Q2
$23M Buy
+592,962
New +$24.9M 3.61% 8

Other funds holding VWO

Aspiriant LLC's VWO Position: Q1 2026 in Review

Aspiriant LLC increased its Vanguard FTSE Emerging Markets ETF (VWO) stake by 7.5% in Q1 2026, buying an estimated $591K and bringing the position to 150,691 shares worth $8.14M. The position accounts for 0.23% of the portfolio, ranked #52.

Aspiriant LLC first reported a position in VWO in Q2 2013 and has held it in 52 quarters since. The position peaked at $34.3M in Q3 2015. 2,536 funds tracked by Wall St. Rank hold VWO as of Q1 2026.

  • Aspiriant LLC held 150,691 shares of Vanguard FTSE Emerging Markets ETF worth $8.14M as of Q1 2026.
  • Aspiriant LLC bought 10,558 Vanguard FTSE Emerging Markets ETF shares in Q1 2026, an estimated $591K.
  • Vanguard FTSE Emerging Markets ETF made up 0.23% of Aspiriant LLC's portfolio in Q1 2026, its #52 holding.
  • Aspiriant LLC first reported a position in Vanguard FTSE Emerging Markets ETF in Q2 2013 and has held it in 52 quarters since.
  • Aspiriant LLC's Vanguard FTSE Emerging Markets ETF position peaked at $34.3M in Q3 2015.
  • 2,536 funds tracked by Wall St. Rank held Vanguard FTSE Emerging Markets ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.